GENEVA, N.Y., May 02, 2018 -- Cheribundi Inc., a leading producer of tart cherry juice products, has teamed up with the Arthritis Foundation as a Champion Sponsor and Official Juice Partner of the Arthritis Foundation’s “Let’s Get a Grip on Arthritis” campaign. The partnership’s goals are to spread awareness about arthritis, help people alleviate their symptoms, and raise money for research.
Arthritis impacts one in four Americans and causes many of them to struggle with everyday activities. Cheribundi and the Arthritis Foundation share a common goal of advancing education and science to improve the quality of life of those who suffer from arthritis.
“As a sponsor of the Arthritis Foundation’s ‘Let’s Get a Grip on Arthritis’ campaign we are showing people that they are not alone in their struggle,” said Steve Pear, Cheribundi CEO. “We are proud to support a cause that we truly believe in. One that aligns with the products we create and our mission to Keep Good In. We know that, together with the Arthritis Foundation, we can change lives for the better and increase the quality of life for those suffering from this disease.” “We are thrilled to have Cheribundi as the official juice partner of our inaugural cause campaign, ‘Let’s Get a Grip on Arthritis,’” said Ann Palmer, President and CEO, Arthritis Foundation. “Arthritis is a debilitating disease that impacts 1 in 4 Americans, and Cheribundi’s commitment in helping raise awareness brings us that much closer to one day having a cure.”
The natural health benefits of tart cherries, like those used in Cheribundi’s juice products, are strongly supported by over 50 scientific studies published in various acclaimed publications, such as the Journal of Nutrition, Journal of Natural Products, British Journal of Sports Medicine and the Scandinavian Journal of Medicine in Science and Sport. Tart cherries contain high levels of anthocyanins that possess anti-inflammatory and antioxidant properties which may help reduce pain and inflammation caused by arthritis.1.2 Study findings also suggest that cherry intake is associated with a lower risk of gout attacks.3
The “Let’s Get a Grip on Arthritis” campaign kicked off May 1, 2018 for National Arthritis Awareness Month. Campaign activities include fundraising efforts, educational programs and personalized support for the nearly 50 million arthritis sufferers in the United States. More information can be found at Arthritis.org/letsgriparthritis.
About Cheribundi
Founded in 2004, Cheribundi produces one of the most unique super fruit juices in the world. Their tart cherry juices are crafted through a one-of-a-kind juicing process, developed by scientists at Cornell University, to create a natural product with incredibly high antioxidant strength. Known for delivering benefits like increased muscle recovery, reduced soreness, immune system support and more effective sleep, Cheribundi tart cherry juices are also one of the best tasting on the market.
Because of its effectiveness, Cheribundi has a unique connection to the athletic world. Over 215 NCAA and professional sports teams, plus thousands of elite and amateur athletes, drink Cheribundi as part of their daily training routines.
Cheribundi tart cherry juice products are available nationwide at cheribundi.com as well as in grocery, natural, and specialty retailers, including Publix, Safeway, Kroger, Target, Wegmans, Whole Foods, Wal-Mart, HEB, Meijer, Costco, Rite Aid, Food Lion, and online at Amazon.com.
For more information about Cheribundi, please visit our website: www.cheribundi.com.
About the Arthritis Foundation
The Arthritis Foundation is the Champion of Yes. Leading the fight for the arthritis community, the Foundation helps conquer everyday battles through life-changing information and resources, access to optimal care, advancements in science and community connections. The Arthritis Foundation’s goal is to chart a winning course, guiding families in developing personalized plans for living a full life – and making each day another stride towards a cure. The Foundation also publishes Arthritis Today, the award-winning magazine that reaches 4 million readers per issue.
- Schumacher HR, Pullman-Mooar S, Gupta SR, Dinnella JE, Kim R, McHugh MP. Randomized double-blind crossover study of the efficacy of a tart cherry juice blend in treatment of osteoarthritis (OA) of the knee. Osteoarthritis Cartilage. 2013 Aug;21(8):1035-41. doi: 10.1016/j.joca.2013.05.009. Epub 2013 May 31. PubMed PMID: 23727631.
- Zhang Y, Neogi T, Chen C, Chaisson C, Hunter DJ, Choi HK. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum. 2012 Dec;64(12):4004-11. doi: 10.1002/art.34677. PubMed PMID: 23023818; PubMed Central PMCID: PMC3510330.
- Wang H, Nair MG, Strasburg GM, Booren AM, Gray JI. Novel antioxidant compounds from tart cherries (Prunus cerasus). J Nat Prod. 1999 Jan;62(1):86-8. PubMed PMID: 9917288.
Press Contacts:
Sarah Nelson | sarah@cheribundi.com | 303-909-6510
Lori Jung | [email protected] | 917-399-6962


Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
World game at war: why some European nations have threatened a World Cup boycott
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Japan Earthquake Disrupts Auto and Chip Supply Chains
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Same sparkle, different story: how lab-grown diamonds are transforming the market
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 



